Jiajian Liu, Caicun Zhou. "Phase 1 study of LB1410, a bivalent TIM-3/PD-1 bispecific antibody, in patients with advanced solid tumors or lymphoma.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.2586